MRTX - Mirati Therapeutics EPS misses by $0.54 May, 06 2021 05:24 PM Mirati Therapeutics Inc. Mirati Therapeutics (MRTX): Q1 GAAP EPS of -$2.67 misses by $0.54.Cash, cash equivalents, and short-term investments of $1.29BPress Release For further details see: Mirati Therapeutics EPS misses by $0.54